Sign Up to like & get
recommendations!
0
Published in 2021 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.0c01222
Abstract: Recently, a lipopeptide derived from the hepatitis B virus (HBV) large surface protein has been developed as an HBV entry inhibitor. This lipopeptide, called MyrcludexB (MyrB), selectively binds to the sodium taurocholate cotransporting polypeptide (NTCP)…
read more here.
Keywords:
enzyme delivery;
hrp;
virus derived;
hrp myrb ... See more keywords